Home › NDC Lookup › Drug shortages › Clindamycin Hydrochloride Capsule

Clindamycin Hydrochloride Capsule shortage

Clindamycin Hydrochloride Capsule is currently listed in shortage by the FDA. The FDA lists 3 affected products. This page was last refreshed from FDA data on Oct 2, 2026.

To Be Discontinued ⚠ Supply risk: High Anti-Infective 3 products 220 days First posted Feb 25, 2026 Updated Feb 25, 2026
Here’s the bottom line

Pfizer is stopping production of clindamycin hydrochloride capsules, and this change may be permanent. Other manufacturers — including Major Pharmaceuticals and Micro Labs Limited — still list all three strengths (75 mg, 150 mg, and 300 mg) as available.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
3
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/3
Affected strengths supplied
220
Days in shortage
11
Medicaid Rx (2026)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 2, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Clindamycin Hydrochloride Capsule. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
3 NDCs
To be discontinued 3
Affected strengths still supplied
Among manufacturers reporting this shortage
0/3 strengths
No supply 3
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Clindamycin Hydrochloride Capsule from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Major Pharmaceuticals Micro Labs Limited A-S Medication Solutions AvPAK Golden State Medical Supply, Inc. St. Mary's Medical Park Pharmacy Chartwell RX, LLC
Plus 3 alternative dosage forms of Clindamycin Hydrochloride.
See all other options & details →
Shortage timeline
  1. Feb 25, 2026
    Currently in shortage
    3 of 3 products affected.
  2. Feb 25, 2026
    First reported to the FDA
    3 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Pfizer Inc. 📞 844-646-4398 3 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02) NDC 00009-0331-02 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02) NDC 00009-0225-02 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14) NDC 00009-0395-14 — — Discontinuation of the manufacture of the drug —

These rows are manufacturer reports to the FDA for Clindamycin Hydrochloride Capsule — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Clindamycin Hydrochloride Capsule? options further down this page.

Why is Clindamycin Hydrochloride Capsule in shortage?

Pfizer has reported to the FDA that it is permanently stopping the manufacturing of its brand-name Cleocin Hydrochloride capsules. This affects all three strengths they made — the 75 mg, 150 mg, and 300 mg capsules. Since this is a full discontinuation rather than a temporary shortage, there is no expected return date for these specific Pfizer products.

It's worth knowing that Pfizer did not share a specific public reason why they made this decision — just that manufacturing is being permanently stopped. Also, this report covers only Pfizer's branded Cleocin product, so it doesn't necessarily reflect the availability of clindamycin capsules made by other manufacturers.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Clindamycin Hydrochloride Capsule, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Clindamycin Hydrochloride Capsule?

Clindamycin hydrochloride capsules are currently on the FDA shortage list. This note explains what that means for you and the practical steps to take.

The shortage record here comes from one manufacturer, Pfizer, and covers all three capsule strengths — 75 mg, 300 mg, and 150 mg. None of these strengths has an available source from that maker right now. The reason given is that Pfizer is discontinuing its manufacture of the drug. Because this is a discontinuation rather than a temporary supply gap, this particular product may not return. That said, this record reflects only one company. Other manufacturers make the same medicine, so it may still be available elsewhere.

Please do not stop, skip, or change your dose on your own. Here is what to do:

  • Keep taking your medicine as prescribed and contact your pharmacy soon.
  • Ask your pharmacy to check other makers — the same clindamycin capsules are made by companies such as Major Pharmaceuticals, Micro Labs, and others. It may not be in local stock, but your pharmacy can often order it.
  • If your strength cannot be found, ask your prescriber or pharmacist about options, such as a clinician-chosen alternative.

Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is general national information and may not match your local pharmacy's stock.

See “Where else can I get Clindamycin Hydrochloride Capsule?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Clindamycin guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Clindamycin guide →

Where else can I get Clindamycin Hydrochloride Capsule?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Clindamycin Hydrochloride Capsule is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 150 mg/1 Capsule · Oral Major Pharmaceuticals 00904-5959-61
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 300 mg/1 Capsule · Oral Major Pharmaceuticals 00904-7194-61
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 75 mg/1 Capsule · Oral Micro Labs Limited 42571-0250-01
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 150 mg/1 Capsule · Oral Micro Labs Limited 42571-0251-01
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 300 mg/1 Capsule · Oral Micro Labs Limited 42571-0252-01
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 150 mg/1 Capsule · Oral A-S Medication Solutions 50090-0443-00
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 300 mg/1 Capsule · Oral A-S Medication Solutions 50090-0967-00
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 300 mg/1 Capsule · Oral AvPAK 50268-0185-15
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 150 mg/1 Capsule · Oral Golden State Medical Supply, Inc. 51407-0373-01
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 150 mg/1 Capsule · Oral St. Mary's Medical Park Pharmacy 60760-0487-28
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 300 mg/1 Capsule · Oral St. Mary's Medical Park Pharmacy 60760-0827-10
Clindamycin Hydrochloride CLINDAMYCIN HYDROCHLORIDE 75 mg/1 Capsule · Oral Chartwell RX, LLC 62135-0764-01

Alternative dosage forms of Clindamycin Hydrochloride

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 30 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Clindamycin hydrochloride 150 mgNDC 00904-5959-61 Major 100 capsules $0.103 AB Availability likely
Clindamycin Hydrochloride 150 mgNDC 42571-0251-01 Micro 100 capsules $0.103 AB Availability likely
clindamycin hydrochloride 150 mgNDC 59762-3328-01 Mylan 100 capsules $0.103 AB Discontinued
Clindamycin Hydrochloride 150 mgNDC 62135-0765-01 Chartwell 100 capsules $0.103 — Availability likely
Clindamycin hydrochloride 150 mgNDC 63304-0692-01 Sun 100 capsules $0.103 AB Availability likely
Clindamycin Hydrochloride 150 mgNDC 65862-0185-01 Aurobindo 100 capsules $0.103 AB Availability likely
Clindamycin Hydrochloride 150 mgNDC 68084-0243-01 American 100 capsules $0.103 AB Availability likely
Clindamycin Hydrochloride 150 mgNDC 68462-0143-01 GLENMARK 100 capsules $0.103 AB Availability likely
Clindamycin Hydrochloride 300 mgNDC 00904-7194-61 Major 100 capsules $0.175 AB Availability likely
Clindamycin Hydrochloride 300 mgNDC 42571-0252-01 Micro 100 capsules $0.175 AB Availability likely
Clindamycin Hydrochloride 300 mgNDC 50268-0185-15 AvPAK 50 capsules $0.175 AB Availability likely
Clindamycin Hydrochloride 300 mgNDC 62135-0766-01 Chartwell 100 capsules $0.175 — Availability likely
Clindamycin hydrochloride 300 mgNDC 63304-0693-01 Sun 100 capsules $0.175 AB Availability likely
Clindamycin Hydrochloride 300 mgNDC 65862-0186-01 Aurobindo 100 capsules $0.175 AB Availability likely
Clindamycin Hydrochloride 300 mgNDC 68084-0244-01 American 100 capsules $0.175 AB Availability likely
Clindamycin Hydrochloride 300 mgNDC 68462-0144-01 GLENMARK 100 capsules $0.175 AB Availability likely
clindamycin hydrochloride 300 mgNDC 59762-5010-01 Mylan 16 capsules $0.176 AB Discontinued
Clindamycin Hydrochloride 75 mgNDC 42571-0250-01 Micro 100 capsules $0.259 AB Availability likely
Clindamycin Hydrochloride 75 mgNDC 62135-0764-01 Chartwell 100 capsules $0.259 AB Availability likely
Clindamycin Hydrochloride 75 mgNDC 68462-0142-01 GLENMARK 100 capsules $0.259 AB Availability likely
Cleocin Hydrochloride 75 mgNDC 00009-0331-02 Pharmacia 100 capsules — AB FDA listed
Clindamycin Hydrochloride 75 mgNDC 76420-0615-01 Asclemed 100 capsules — AB FDA listed
Cleocin Hydrochloride 150 mgNDC 00009-0225-02 Pharmacia 100 capsules — AB FDA listed
Clindamycin Hydrochloride 150 mgNDC 50090-0443-00 A-S 30 capsules — AB FDA listed
Clindamycin hydrochloride 150 mgNDC 50090-1985-00 A-S 30 capsules — AB FDA listed
Clindamycin Hydrochloride 150 mgNDC 50090-4661-00 A-S 30 capsules — AB FDA listed
Clindamycin hydrochloride 150 mgNDC 50090-7007-00 A-S 100 capsules — AB FDA listed
Clindamycin Hydrochloride 150 mgNDC 50090-7374-00 A-S 30 capsules — AB FDA listed
Clindamycin hydrochloride 150 mgNDC 51407-0373-01 Golden 100 capsules — AB FDA listed
Clindamycin Hydrochloride 150 mgNDC 51655-0710-52 Northwind 30 capsules — AB FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Clindamycin Hydrochloride Capsule — that fall in the same broad treatment class (lincosamide antibiotics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 009341
GCN 40831
HICL code 004044
Ingredient (HICL) Clindamycin Hcl
HIC1 code W
Therapeutic class — broad (HIC1) Anti-Infecting Agents
HIC2 code W1
Therapeutic class — intermediate (HIC2) Antibiotics
HIC3 code W1K
Therapeutic class — specific (HIC3) Lincosamide Antibiotics
AHFS code 08:12.28.20
AHFS class Lincomycin Antibiotics
FDB label name CLEOCIN HCL 75 MG CAPSULE
FDB brand name Cleocin Hcl
Legend status F — Federal legend — prescription drug or device
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other anti-infective shortages

Clindamycin Hydrochloride Capsule shortage FAQs

Is Clindamycin Hydrochloride Capsule in shortage?
Yes — the FDA currently lists Clindamycin Hydrochloride Capsule in shortage (status: “To Be Discontinued”, first reported Feb 25, 2026). 3 of 3 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02) (NDC 00009-0331-02); Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02) (NDC 00009-0225-02); Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14) (NDC 00009-0395-14). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Clindamycin Hydrochloride Capsule be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Clindamycin Hydrochloride somewhere?
Other manufacturers (Major Pharmaceuticals, Micro Labs Limited, A-S Medication Solutions and others) still market it and have not reported a shortage. 3 alternative dosage forms of Clindamycin Hydrochloride are also listed. See “Where else can I get Clindamycin Hydrochloride Capsule?” above — stock still varies by pharmacy.
What should I do if I take Clindamycin Hydrochloride Capsule?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Clindamycin Hydrochloride Capsule shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages